• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Cumulus Neuroscience

To add a bio or update company history, please click update information.

News from Cumulus Neuroscience

    Cumulus Neuroscience secures £3m in funding led by Whiterock to scale AI-powered neurology trialsCumulus Neuroscience secures £3m in funding led by Whiterock to scale AI-powered neurology trials
    Cumulus Neuroscience
    8 Jul 2025

    Cumulus Neuroscience secures £3m in funding led by Whiterock to scale AI-powered neurology trials

    Cumulus Neuroscience supports clinical trials with AI powered brain data collection tools, combining wearable EEG hardware and digital assessments to improve neurological research and drug development.

Cumulus Neuroscience
  • Health
  • Belfast, United Kingdom
  • £3m
  • cumulusneuro.com
  • Update Information

More venture news

  • Anemo Labs raises a £700k pre-seed round led by Zinc and SFC Capital to build electronic nose that detects disease signals in smell
    Anemo Labs
    9 Sept 2026

    Anemo Labs raises a £700k pre-seed round led by Zinc and SFC Capital to build electronic nose that detects disease signals in smell

    Pre-seedHealth
  • Strolll secures £4.3m in funding from Innovate UK and IW Capital for augmented reality neurorehabilitation
    Strolll
    3 Sept 2026

    Strolll secures £4.3m in funding from Innovate UK and IW Capital for augmented reality neurorehabilitation

    EquityHealth
  • Healf secures funding led by SEMCAP Beauty & Wellness to expand its personalised wellbeing platform
    Healf
    1 Sept 2026

    Healf secures funding led by SEMCAP Beauty & Wellness to expand its personalised wellbeing platform

    EquityHealth

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn